Magnesium-enhanced enzymatically mineralized platelet-rich fibrin for bone regeneration applications.
Membranes of the autologous blood-derived biomaterial platelet-rich fibrin (PRF) were mineralized enzymatically with calcium phosphate (CaP) by the incorporation of alkaline phosphatase (ALP) followed by incubation for 3 days in solutions of either 0.1 M calcium glycerophosphate (CaGP) or a combination of CaGP and magnesium glycerophosphate (CaGP:MgGP; both 0.05 M), resulting in the formation of two different PRF-mineral composites. Fourier transform infrared spectroscopy, transmission electron microscopy and selected area electron diffraction examinations showed that the CaP formed was amorphous. Inductively coupled plasma optical emission spectroscopy analysis revealed similar amounts of Ca and P in both composite types, while a smaller amount of Mg (Ca:Mg molar ratio = 10) was detected in the composites formed in the CaGP:MgGP solution, which was supported by the results of energy-dispersive x-ray spectroscopy-based elemental mapping. Scanning electron microscopy (SEM) imaging showed that the mineral deposits in PRF incubated in the CaGP:MgGP solution were markedly smaller. The mass percentage attributable to the mineral phase was similar in both composite types. MTT and WST tests with SAOS-2 cells revealed that incubation in the CaGP:MgGP solution had no negative effect on cytocompatibility and cell proliferation compared to the CaGP solution. Cells on all samples displayed a well-spread morphology as revealed by SEM imaging. In conclusion, the incorporation of Mg reduces mineral deposit dimensions and promotes cell proliferation.
Clinic of Oral and Maxillofacial Surgery, University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller-Str. 3, Haus 26, D-24105 Kiel, Germany.
Volker
V
Gassling
Timothy E L
TE
Douglas
Nicolai
N
Purcz
David
D
Schaubroeck
Lieve
L
Balcaen
Vitaliy
V
Bliznuk
Heidi A
HA
Declercq
Frank
F
Vanhaecke
Peter
P
Dubruel
D000469:Alkaline Phosphatase / Q000378:metabolism; D001672:Biocompatible Materials / Q000737:chemistry*; D001861:Bone Regeneration; D018786:Bone Substitutes / Q000737:chemistry*; D045744:Cell Line, Tumor; D005337:Fibrin / Q000737:chemistry*; D005994:Glycerophosphates / Q000737:chemistry; D006801:Humans; D020100:Hydrogels / Q000737:chemistry; D008274:Magnesium / Q000737:chemistry*; D008855:Microscopy, Electron, Scanning; D046529:Microscopy, Electron, Transmission; D013053:Spectrophotometry; D017550:Spectroscopy, Fourier Transform Infrared; D013778:Tetrazolium Salts; D013844:Thiazoles
D001672:Biocompatible Materials; D018786:Bone Substitutes; D005994:Glycerophosphates; D020100:Hydrogels; D013778:Tetrazolium Salts; D013844:Thiazoles; D005337:Fibrin; D000469:Alkaline Phosphatase; C022616:thiazolyl blue; D008274:Magnesium